Welcome to our dedicated page for QuantumScape SEC filings (Ticker: QS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on QuantumScape's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into QuantumScape's regulatory disclosures and financial reporting.
QuantumScape Corp director Jeffrey B. Straubel sold 27,106 shares of Class A Common Stock in an open-market transaction at a weighted average price of $7.1003 per share. The sale was executed under a Rule 10b5-1 trading plan adopted on June 13, 2025.
Following this sale, Straubel reports beneficial ownership of 212,616 shares, including 48,192 shares represented by restricted stock units that vest over time, subject to his continued service.
QuantumScape Corporation filed a Form 144 notice reporting proposed sales of Class A common stock by Timothy Holme and The Holme 2020 Irrevocable Trust. The filing lists multiple past sales on 11/19/2025, 12/04/2025, and 01/05/2026, with per‑trade share counts and dollar amounts.
The filing includes examples of past transactions, including Timothy Holme selling 96,712 shares for $1,200,805.21 on 11/19/2025 and The Holme 2020 Irrevocable Trust selling 25,838 shares for $320,812.36 on 11/19/2025. The notice also lists several restricted stock unit acquisitions dated 02/15/2026.
QuantumScape insider reported sales of Class A common stock. Jeffrey B. Straubel reported multiple dispositions, including 130,065 shares sold on 12/19/2025 for $1,485,251.25, 27,106 shares sold on 12/19/2025 for $303,749.84, and 27,106 shares sold on 01/05/2026 for $305,690.63. The filings state the shares were acquired as Restricted Stock Units on 03/17/2011.
Timothy Holme and The Holme 2020 Irrevocable Trust reported proposed sales of Class A common stock on Form 144. The filing lists multiple recent dispositions: examples include 201,785 shares sold by Timothy Holme on 11/19/2025 for $2,524,422.34 and 166,440 shares sold on 12/04/2025 for $2,112,123.60.
QS affiliate reports proposed resale and recent transactions. Kevin Hettrich filed a Form 144 showing an RSU vesting of 217,531 Class A Common Stock on 02/17/2026 related to compensation.
The filing also lists earlier dispositions by Mr. Hettrich, including 78,424 shares on 11/18/2025 and 9,800 shares on 12/15/2025, with dollar amounts shown per trade.
Notice of proposed sale of Class A Common Stock by insiders and related holders. The filing lists 218,693 shares of Class A Common Stock tied to RSU vesting with an effective date of 02/17/2026 and labeled Compensation.
The excerpt also reports recent sales: Michael O. McCarthy III sold 59,108 shares on 11/18/2025 (proceeds $770,862.89) and 758 shares on 11/18/2025 (proceeds $10,203.36); Chesapeake Nevada Trust sold 36,415 shares on 11/24/2025 (proceeds $422,530.53) and 40,000 shares on 11/25/2025 (proceeds $471,652.00).
Mohit Singh submitted a Form 144 reporting proposed sales of Class A Common Stock. The filing lists 239,518 shares associated with RSU vesting on 02/17/2026 described as compensation. It also discloses prior sales of 78,013 and 1,000 shares on 11/18/2025. The filing shows 562,404,592 shares with a date of 02/18/2026.
Sivaram Srinivasan filed a Form 144 reporting proposed dispositions of Class A Common Stock. The filing lists an RSU vesting of 529,289 shares on 02/17/2026 and prior sales on 11/18/2025 of 255,403 and 3,274 shares, with dollar amounts shown for those past sales.
QuantumScape Corporation reported fourth quarter and full-year 2025 results and outlined its 2026 goals. The company achieved key 2025 milestones, including integrating its Cobra process into production, shipping Cobra-based QSE-5 cells to the Volkswagen Group, expanding commercial engagements with additional global automotive OEMs, and installing its Eagle Line pilot cell production line.
For Q4 2025, GAAP operating expenses were $110.5M and GAAP net loss was $100.1M$472.6M and GAAP net loss was $435.1M. Full-year 2025 Adjusted EBITDA loss was $252.3M, representing an approximately 10% year-over-year improvement. Capital expenditures were $36.3M for 2025 and are expected to be $40M–$60M in 2026. Customer billings were $19.5M in 2025, and liquidity at year-end totaled $970.8M.
For 2026, QuantumScape expects full-year Adjusted EBITDA loss between $250M and $275M as it focuses on demonstrating scalable production on the Eagle Line, advancing automotive commercialization, expanding into new high-value markets, and progressing beyond its current QSE-5 platform.